New sudan ebola vaccine shows promise in phase 2 trial
⭐️ VACCINE ⭐️
Completed
This study tested a new vaccine designed to protect against Sudan ebolavirus, a deadly virus similar to Ebola. Researchers gave the vaccine or a placebo to 125 healthy adults to check if it is safe and triggers a strong immune response. The goal is to find a way to prevent this s…
Phase: PHASE2 • Sponsor: Albert B. Sabin Vaccine Institute • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 14:04 UTC